Welcome to the Future of Cell & Gene Therapy The 3rd In Vivo Cell Engineering & Gene Editing Summit is an annual event uniting C-level in vivo experts to facilitate safe and targeted in vivo delivery of payloads while providing clarity in regulations and appropriate models to advance the next frontier of in vivo editing […]

Fast-Track Your mRNA-Based Therapeutics & Vaccines from Discovery to Commercialization by Ensuring Targeted Delivery, Durability & Tolerable Immunogenicity Across All Disease Indications As mRNA developments continue to dominate industry news, ranging from winning the Nobel Prize to new clinical candidates, positive Phase I readouts and approvals, the industry is set to reunite in Boston this […]

The 5th Gamma Delta T Cell Therapies Summit will bring together experts from big pharma, biotech and academia to delve into the details of gamma delta biology and its various subsets to offer the audience a well-rounded overview of the landscape currently and the steps needed for it to move forward. Find out more here: […]

There has been many exciting investments and advancements in the field, such as Atavistik Bio raising an additional $40 million to advance their small molecule therapeutics and Servier and Base4 expanding their partnership to accelerate development of neuroscience drugs. However, the discovery of potent RNA targeting small molecules is plagued by limited robust assays and […]

Optimize Safety & De-Risk Efficacy of Viral Vector-Based Gene Therapies The success of gene therapy hinges on overcoming the immunogenicity challenges of viral vectors. With more viral vector-based gene therapies progressing through the pipeline, we need to seek solutions to this critical bottleneck ‘here and now’. The 5th Gene Therapy Immunogenicity Summit is returning to Boston this […]

With Eli Lilly's acquisition of Mablink and Novartis' investment in Tagworks, both centering on their innovative linker and conjugation technologies - optimizing linker chemistry and diversifying conjugation technologies to increase stability and selectivity are becoming increasingly more attractive to ADC developers as they strive for a competitive edge over their peers. As part of the World ADC Series, the 2nd ADC Linker […]

Delivering on the Promise of Precision Medicine with Digital Measures in Neurology Harnessing More Quantitative, Objective & Less Invasive Measures to Reduce Costs & Improve Neurology Patient Experience 2023 welcomed SV95C as the first ever digital endpoint qualified by a regulatory agency, which means that the floodgates have now opened to the potential of digital biomarkers to […]

Exclusively dedicated to uniting AD, QC, and CMC leaders the 3rd Oligonucleotide CMC & Analytical Development Summit is the only industry-led meeting solving your impurity, regulatory, and cost-efficiency challenges in this rapidly evolving field. Across the three days, you'll get the chance to hear from KOLs like Ionis Pharmaceuticals, AstraZeneca, and CAMP4 Therapeutics as the […]

Bringing together technical experts, the 3rd Cell Therapy Analytical Development Summit Europe, is the definitive summit dedicated to defining and refining analytics to ensure the swift progression of highly efficacious products through IND/IMPD and clinical trials. Connect with industry-leaders like Achilles Therapeutics, Avobis Bio, Bristol Myers Squibb, Johnson & Johnson, GSK, MHRA, to advance the future development of potent, safe and effective cell therapies! Join […]

The Wearable Injectors and Connected Devices event is the only conference that discusses both wearable injectors and connected devices in one event. Over two days, we bring together executives within the pharmaceutical industry to discuss the opportunities and challenges that face on-body devices, and to collaborate on the future of the industry. The event provides […]

Major moves in pharma and biotech partnering are reshaping the landscape. For ADC companies, the challenge lies in standing out, validating their offerings, and securing clinical-ready assets amidst this whirlwind of activity. How does one differentiate and obtain assets poised for clinical success in the next wave of deals? Enter the ADC & Radiopharmaceuticals Pharma […]

SAE Media Group are proud to announce the inaugural Pre-Filled Syringes Connect event taking place on the 11th and 12th of September in Boston. As a new addition to SAE's leading injectable drug delivery portfolio, PFS Connect will bring together device thought-leaders from big pharma, biotech and device developers in an intimate, relaxed and engaging […]

The commercial success of cell therapies is continuing to grow! With a recent TIL approval, a shift to earlier line CAR-T treatment, and further approvals set for this year, 2024 will be pivotal to demonstrate the clinical benefit of cell therapies and advance breakthroughs in solid tumors and autoimmunity. That’s why now’s the time to […]

Develop, characterize, and validate robust analytical tools that demonstrate safety, efficacy, and regulatory compliance of genome editing therapies As CRISPR-based therapies become ever-complex, drug developers urgently need to innovate the analytical tools available to effectively characterize their safety and efficacy profiles and agree upon gold standards moving forward. We are also witnessing increased regulatory scrutiny, […]

Your Roadmap for mRNA Process Development & Manufacturing with Optimized Purification, Process Analytics & Enhanced Formulation to Improve Cost-Effectiveness & Scalability into the Clinic & Beyond The mRNA manufacturing industry is experiencing a wave of innovation with the development of cancer vaccines, emerging therapeutics, and novel gene editing tools. Yet, significant challenges remain – largely […]

With cutting-edge strategies and industry insights, the 2nd ADC Process Development Summit is back with a mission to boost conjugation yield, optimize purification, and streamline production to meet regulatory standards all whilst minimizing costs and timelines. Join AstraZeneca, Bristol Myers Squibb, Pfizer and a community of industry experts in process development, conjugation, purification, control, CMC, […]

The race to target the remaining RAS mutants continues, with over 24 clinical and 70 pre-clinical stage programs striving for first- and best-in-class. Now more than ever, we are witnessing this growing industry make strides to utilize novel modalities and elucidate mechanisms of resistance – making treating patients with RAS mutant cancers beyond NSCLC not […]

Join us for an exploration of accelerating drug development, streamlining clinical trials and enhancing supply chain efficiency to elevate patient care across the entire value stream at the AI for Pharma & Healthcare Summit! Imagine a world where drug discovery moves at unprecedented speeds, clinical trials are streamlined for efficiency, and regulatory approvals are faster […]

With Rezdiffra’s approval, GLPs moving into the space, and the wave of promising therapeutics in phrase I-III trials, MASH therapeutics have seen an unprecedented boom in recent months. Don't miss the 8th MASH Drug Development Summit's industry-specific curated agenda spanning preclinical, translational, clinical and regulatory MASH developments designed to help you to overcome barriers in […]

Learning From the Past & Spearheading Macrophage Clinical Acceleration The 6th Macrophage-Directed Therapies Summit is uniting 60+ biopharma and academia leaders across R&D, Discovery, Biology, Translational, and Clinical Development fields for invaluable networking and insights into all facets of macrophage-directed therapies. Grab your Full Agenda – https://ter.li/nqf2qd Despite toxicity concerns for CD47 targets in 2023, […]

With Kenai Therapeutics emerging from stealth with an $82 Million Series A funding round, 2024 has started strong for iPSC drug developers looking to showcase the potential of their pipelines ahead of the next wave of investment. Introducing the 4th iPSC Drug Development & Manufacturing Summit, your longest standing and definitive iPSC focused platform. No iPSC stone will be […]

SAE Media Group’s 5th Annual Wearable Injectors and Connected Devices Conference will explore on-body device design and development whilst also engaging in the latest advances in connectivity and digital health applications for wearable devices with industry perspectives from big pharma representatives. The conference will consider key developments in the wearable injectors field, including the enhanced […]

Are you listening to your patient community? It’s not enough. Standing in the shadows and harvesting anecdotal insights won’t build connections, create first-hand knowledge or illuminate your impact to internal stakeholders. We must step forward and be visible, actively engaging in patient communities and embedding the patient voice internally. YOU are the patient advocate in […]

Following the watershed approval of Iovance’s Lifileucel, all eyes are now on TIL therapies as the up-and-coming major therapeutic avenue for solid tumor treatment. Introducing the 6th Annual TIL Therapies Summit! With 30+ expert speakers, 12 new speaker companies, 2 brand-new content-filled tracks and 2 brand-new interactive workshops, you won't want to miss out! Hear […]

The 5th Commercializing Flow Chemistry Summit marks a pivotal year, introducing a significant shift in content to address the evolving needs of the pharmaceutical manufacturing industry. This summit zeroes in on advanced scale-up capabilities and stakeholder engagement strategies, responding to a market that is rapidly expanding and forecasted to reach US $4.6 billion by 2032. […]

𝘞𝘢𝘯𝘵 𝘵𝘰 𝘜𝘯𝘥𝘦𝘳𝘴𝘵𝘢𝘯𝘥 𝘎𝘶𝘪𝘥𝘢𝘯𝘤𝘦, 𝘚𝘵𝘳𝘦𝘢𝘮𝘭𝘪𝘯𝘦 𝘚𝘶𝘣𝘮𝘪𝘴𝘴𝘪𝘰𝘯𝘴, & 𝘖𝘣𝘵𝘢𝘪𝘯 𝘈𝘱𝘱𝘳𝘰𝘷𝘢𝘭? The knowledge and connections you gain at the 𝗖𝗲𝗹𝗹 & 𝗚𝗲𝗻𝗲 𝗧𝗵𝗲𝗿𝗮𝗽𝘆 𝗥𝗲𝗴𝘂𝗹𝗮𝘁𝗼𝗿𝘆 𝗔𝗳𝗳𝗮𝗶𝗿𝘀 𝗦𝘂𝗺𝗺𝗶𝘁 will make the difference between success and delay in your IND and BLA applications. You'll hear from top regulatory experts like David Uguen (𝗢𝗿𝗰𝗵𝗮𝗿𝗱 𝗧𝗵𝗲𝗿𝗮𝗽𝗲𝘂𝘁𝗶𝗰𝘀), Shirley Bartido (𝗧𝗮𝗸𝗲𝗱𝗮 𝗣𝗵𝗮𝗿𝗺𝗮𝗰𝗲𝘂𝘁𝗶𝗰𝗮𝗹𝘀), Yao-Yao Zhu […]

With a flurry of high capital collaborations and partnership deals from the likes of C4T, Merck KgGA, Monte Rosa, Proxygen, Orum, and momentum building in clinic with BTK degraders, ER degraders and many more assets. It has never been more import to re-join forces at the 7th TPD & Induced Proximity Summit, the longest standing and most comprehensive protein degradation and proximity based […]

Twelve gene therapies have been approved by the FDA to date to treat a variety of diseases, including the first ever gene edited therapeutic. The CMC package required to effectively demonstrate safety and efficacy of increasingly complex gene therapy products to regulators needs to keep pace. The 6th Gene Therapy Analytical Development & CMC Summit […]

Spurred by George Schett and Andreas Mackensen’s remarkable CAR-T results in SLE, the immunotherapy revolution for autoimmune diseases is the next “million-dollar question”. The Autoimmunity Pharma & Biotech Partnering Summit is the only event of its kind, laying enabled partnering on top of hyper-relevant scientific discussion specifically for immune reset and reconstitution therapies. VIEW THE […]

The Advanced Therapies Congress showcases the future of advanced therapies. Bringing Europe’s largest cell and gene therapy conference and exhibition to Philadelphia, the event is for the leaders of the world’s ATMP developers and their most senior executives in charge of the latest tech and strategies that are driving the industry forward. This year, we will be expecting 1000+ […]